Type 2 & other diabetes

The association between the triglyceride–glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study

Cardiovasc DiabetolPublished Cross-sectional study

Authors' conclusion

A higher TyG index was linked to an increased likelihood of CVD in the U.S. population aged ≤ 65 years with prediabetes and diabetes. Besides, TyG index assessment will contribute to more convenient and effective screening of high-risk individuals in patients with MetS. Future studies should explore whether interventions targeting the TyG index may improve clinical outcomes in these patients.

Study context

Population
US participants aged ≤65 years with diabetes or prediabetes, National Health and Nutrition Examination Survey (NHANES) 2003–2018
Participants
4,340 participants
Exposure
Triglyceride-glucose (TyG) index quartiles
Outcome
CVD risk in relation to baseline TyG index
Methodological detailspopulation-based, NHANES 2003-2018, multivariate regression, restricted cubic splines, subgroup analysis and interaction tests
  • Population-based
  • NHANES 2003-2018
  • Multivariate regression
  • Restricted cubic splines
  • Subgroup analysis and interaction tests

Main finding

As reported in the abstract

CVD prevalence by TyG quartile
Overall average prevalence of cardiovascular disease (CVD)
10.38%
Mean TyG index
9.02 ± 0.02

Observational data: associations, not effects.

Further findings

CVD and CHF in individuals with diabetes (U-shaped relationship)

U-shaped relationship TyG index and CVD risk
P nonlinear = 0.02583
U-shaped relationship TyG index and CHF risk
P nonlinear = 0.0208

Subgroup analysis and interaction

No significant difference among different stratifications

Comorbid MetS

Positive association between TyG index and comorbid MetS

Original publication

The association between the triglyceride–glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. Published 13 May 2024. doi:10.1186/s12933-024-02261-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.